Cargando…
Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis
BACKGROUND: Tamoxifen was recommended by NICE in 2013 for chemoprevention of breast cancer, but a recent survey suggested only a quarter of GPs are aware of this. We set out to measure the uptake of tamoxifen, and the alternative raloxifene, in national prescribing data sets. METHODS: Tamoxifen and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943266/ https://www.ncbi.nlm.nih.gov/pubmed/29681615 http://dx.doi.org/10.1038/s41416-018-0065-2 |